NOTCH3 and Miyoshi myopathy: Further, Wang et al. [66] demonstrated that treatment with sophocarpine triflorohydrazone (SCA), an alkaloid acting as an inhibitor of Notch receptor 3, decreased MM cell viability, activated apoptosis, and decreased Notch receptor 3 expression in vitro, in 2 different MM cell lines[66].